29838-46-8 Usage
Uses
Used in Pharmaceutical Applications:
Barbatic acid is used as an active compound for determining anti-tumor activity, particularly in the context of H22 tumor-bearing mice. Its potential in modulating oncological signaling pathways and exerting inhibitory effects on tumor growth and progression is currently under investigation.
Used in Anticancer Research:
In the field of anticancer research, barbatic acid is utilized to explore its synergistic effects when combined with conventional chemotherapeutic drugs. This application aims to enhance chemo-sensitivity and improve the overall efficacy of cancer treatments, especially in resistant cases.
Used in Drug Delivery Systems:
To overcome potential limitations of barbatic acid, such as bioavailability and delivery issues, researchers are developing novel drug delivery systems. These systems may involve the use of various organic and metallic nanoparticles as carriers for barbatic acid, with the goal of improving its therapeutic outcomes in cancer treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 29838-46-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,8,3 and 8 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 29838-46:
(7*2)+(6*9)+(5*8)+(4*3)+(3*8)+(2*4)+(1*6)=158
158 % 10 = 8
So 29838-46-8 is a valid CAS Registry Number.
InChI:InChI=1/C17H32O4/c1-3-4-5-6-7-8-9-10-11-12-13-15(17(20)21)14(2)16(18)19/h14-15H,3-13H2,1-2H3,(H,18,19)(H,20,21)
29838-46-8Relevant academic research and scientific papers
Highly Diastereoselective Conjugate Addition to Alkylidene Bis(Sulfoxides): Asymmetric Synthesis of (+)-erythro-Roccellic Acid
Brebion, Franck,Delouvrie, Benedicte,Najera, Francisco,Fensterbank, Louis,Malacria, Max,Vaissermann, Jacqueline
, p. 5342 - 5345 (2007/10/03)
Facial stereocontrol is possible in Michael additions of nucleophiles (Nu) to alkylidene bis(sulfoxides), which proceed via nonchelated (A) or chelated (B) intermediates depending on the addition of an appropriate Lewis acid (LA). This intriguing reactivi
First efficient synthesis of (±)-erythro-roccellic acid
Mangaleswaran,Argade
, p. 1764 - 1766 (2007/10/03)
An easy, four-step route to (±)-erythro-2-dodecyl-3-methylbutanedioic acid (roccellic acid, 9) with 60% overall yield has been described. Wittig reaction of the citraconimide-TPP adduct with dodecanal furnished the mixture of (E)- and (Z)-isomers 3 and 4,
